Hiromichi Iwamura
Hirosaki University, Tohoku Medical and Pharmaceutical University
Papers
4
Total Citations
35
H-Index
4
About
Dr. Hiromichi Iwamura is a leading urologic surgeon whose research focuses on optimizing outcomes in robot-assisted radical prostatectomy (RARP) for prostate cancer, particularly in older and vulnerable patient populations. His major contributions center on integrating geriatric assessment into surgical decision-making. In his landmark FRARP-QL Study (2020, 12 citations), Dr. Iwamura demonstrated that preoperative frailty significantly predicts postoperative declines in both quality of life and lower urinary tract symptoms, establishing frailty as a critical factor in patient counseling. His 2021 study (14 citations) further showed that men aged ≥75 can achieve excellent oncologic and patient-reported outcomes after RARP, challenging age-based treatment biases. Dr. Iwamura has also advanced surgical technique through intraoperative electrical stimulation mapping (2019, 4 citations), identifying nerves posterior to the prostate base that are crucial for erectile function—a finding with direct implications for nerve-sparing surgery. In a large comparative analysis (2023, 5 citations, n=452), he evaluated neoadjuvant chemohormonal therapy versus extended lymph-node dissection in high-risk disease, providing evidence to guide treatment selection. With cumulative citations exceeding 35, Dr. Iwamura’s work bridges geriatric oncology, functional outcomes, and surgical innovation, offering actionable insights for clinicians caring for older men with prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4